Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hartadinata Abadi Tbk. (HRTA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Hartadinata Abadi Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Hartadinata Abadi Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Hartadinata Abadi Tbk. trades at Rp2,170 (market cap 10.22T, 8.43M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: Hartadinata Abadi Tbk. is far larger — about 14.8× UBC Medical Indonesia Tbk.'s market cap, and Hartadinata Abadi Tbk. is more actively traded (8.43M versus 635.5K). Which is the better fit depends on your goals.

HRTALABS
Market Cap
10.22T691.25B
Volume
8.43M635.5K
Lot
84.33K6.36K
Turnover
18.32B110.15M
Average Price
2,172.18173.33
Value
18.32B110.15M
Indicative Equilibrium Price
2,170174
Indicative Equilibrium Volume
1.46K50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTA
View details
LABS
View details

About Hartadinata Abadi Tbk.

PT Hartadinata Abadi Tbk (“the Company”) was established based on Notarial Deed No. 11 datedMarch 29, 2004 of Mayasari Soegiharto, S.H.

Read more on HRTA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS